Literature DB >> 21076780

Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates.

Armin Thalhammer1, Jasmin Mecinović, Christoph Loenarz, Anthony Tumber, Nathan R Rose, Tom D Heightman, Christopher J Schofield.   

Abstract

Based on structural analysis of the human 2-oxoglutarate (2OG) dependent JMJD2 histone N(ε)-methyl lysyl demethylase family, 3-substituted pyridine 2,4-dicarboxylic acids were identified as potential inhibitors with possible selectivity over other human 2OG oxygenases. Microwave-assisted palladium-catalysed cross coupling methodology was developed to install a diverse set of substituents on the sterically demanding C-3 position of a pyridine 2,4-dicarboxylate scaffold. The subsequently prepared di-acids were tested for in vitro inhibition of the histone demethylase JMJD2E and another human 2OG oxygenase, prolyl-hydroxylase domain isoform 2 (PHD2, EGLN1). A subset of substitution patterns yielded inhibitors with selectivity for JMJD2E over PHD2, demonstrating that structure-based inhibitor design can enable selective inhibition of histone demethylases over related human 2OG oxygenases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076780      PMCID: PMC4733660          DOI: 10.1039/c0ob00592d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  26 in total

Review 1.  Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases.

Authors:  Nima Mosammaparast; Yang Shi
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  2-Oxoglutarate oxygenases are inhibited by a range of transition metals.

Authors:  Rok Sekirnik; Nathan R Rose; Jasmin Mecinović; Christopher J Schofield
Journal:  Metallomics       Date:  2010-05-20       Impact factor: 4.526

3.  Expanding chemical biology of 2-oxoglutarate oxygenases.

Authors:  Christoph Loenarz; Christopher J Schofield
Journal:  Nat Chem Biol       Date:  2008-03       Impact factor: 15.040

4.  Oxygenase catalyzed 5-methylcytosine hydroxylation.

Authors:  Christoph Loenarz; Christopher J Schofield
Journal:  Chem Biol       Date:  2009-06-26

5.  Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II).

Authors:  Rok Sekirnik; Nathan R Rose; Armin Thalhammer; Peter T Seden; Jasmin Mecinović; Christopher J Schofield
Journal:  Chem Commun (Camb)       Date:  2009-09-28       Impact factor: 6.222

6.  Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors.

Authors:  Shohei Hamada; Takayoshi Suzuki; Koshiki Mino; Koichi Koseki; Felix Oehme; Ingo Flamme; Hiroki Ozasa; Yukihiro Itoh; Daisuke Ogasawara; Haruka Komaarashi; Aiko Kato; Hiroki Tsumoto; Hidehiko Nakagawa; Makoto Hasegawa; Ryuzo Sasaki; Tamio Mizukami; Naoki Miyata
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

7.  Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry.

Authors:  Mukram M Mackeen; Holger B Kramer; Kai-Hsuan Chang; Matthew L Coleman; Richard J Hopkinson; Christopher J Schofield; Benedikt M Kessler
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

8.  Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Authors:  Shohei Hamada; Tae-Dong Kim; Takayoshi Suzuki; Yukihiro Itoh; Hiroki Tsumoto; Hidehiko Nakagawa; Ralf Janknecht; Naoki Miyata
Journal:  Bioorg Med Chem Lett       Date:  2009-03-26       Impact factor: 2.823

9.  Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor.

Authors:  G Tschank; D G Brocks; K Engelbart; J Mohr; E Baader; V Günzler; H M Hanauske-Abel
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

10.  Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches.

Authors:  Nathan R Rose; Esther C Y Woon; Guy L Kingham; Oliver N F King; Jasmin Mecinović; Ian J Clifton; Stanley S Ng; Jobina Talib-Hardy; Udo Oppermann; Michael A McDonough; Christopher J Schofield
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

View more
  22 in total

Review 1.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 3.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

4.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

Review 5.  A chemical probe toolbox for dissecting the cancer epigenome.

Authors:  Jake Shortt; Christopher J Ott; Ricky W Johnstone; James E Bradner
Journal:  Nat Rev Cancer       Date:  2017-02-23       Impact factor: 60.716

6.  DESIGN, SYNTHESIS, AND EVALUATION OF A FAMILY OF PROPARGYL PYRIDINYL ETHERS AS POTENTIAL CYTOCHROME P450 INHIBITORS.

Authors:  Maryam Foroozesh; Quan Jiang; Jayalakshmi Sridhar; Jiawang Liu; Brandan Dotson; Erika McClain
Journal:  J Undergrad Chem Res       Date:  2013

7.  KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes.

Authors:  Lingling Duan; Ganesha Rai; Carlos Roggero; Qing-Jun Zhang; Qun Wei; Shi Hong Ma; Yunyun Zhou; John Santoyo; Elisabeth D Martinez; Guanghua Xiao; Ganesh V Raj; Ajit Jadhav; Anton Simeonov; David J Maloney; Josep Rizo; Jer-Tsong Hsieh; Zhi-Ping Liu
Journal:  Chem Biol       Date:  2015-09-10

8.  Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.

Authors:  Joyce Sayegh; Jian Cao; Mike Ran Zou; Alfonso Morales; Lauren P Blair; Michael Norcia; Denton Hoyer; Alan J Tackett; Jane S Merkel; Qin Yan
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

Review 9.  Design of small molecule epigenetic modulators.

Authors:  Boobalan Pachaiyappan; Patrick M Woster
Journal:  Bioorg Med Chem Lett       Date:  2013-11-13       Impact factor: 2.823

10.  Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.

Authors:  Magdalena Korczynska; Daniel D Le; Noah Younger; Elisabet Gregori-Puigjané; Anthony Tumber; Tobias Krojer; Srikannathasan Velupillai; Carina Gileadi; Radosław P Nowak; Eriko Iwasa; Samuel B Pollock; Idelisse Ortiz Torres; Udo Oppermann; Brian K Shoichet; Danica Galonić Fujimori
Journal:  J Med Chem       Date:  2015-12-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.